Cite

HARVARD Citation

    Sanford, R. et al. (2015). High incidence of germline BRCA mutation in patients with ER low‐positive/PR low‐positive/HER‐2 neu negative tumors. Cancer. 121 (19), pp. 3422-3427. [Online]. 
  
Back to record